MX9704079A - Liberacion de farmacos antiinflamatorios no esteroides empleando uan goam hidrocoloide en polvo que se obtiene de plantas superiores. - Google Patents

Liberacion de farmacos antiinflamatorios no esteroides empleando uan goam hidrocoloide en polvo que se obtiene de plantas superiores.

Info

Publication number
MX9704079A
MX9704079A MX9704079A MX9704079A MX9704079A MX 9704079 A MX9704079 A MX 9704079A MX 9704079 A MX9704079 A MX 9704079A MX 9704079 A MX9704079 A MX 9704079A MX 9704079 A MX9704079 A MX 9704079A
Authority
MX
Mexico
Prior art keywords
nsaid
composition
higher plants
hydrocolloid gum
gum obtainable
Prior art date
Application number
MX9704079A
Other languages
English (en)
Inventor
Eric H Kuhrts
David R Friend
Karen Yu
Jagdish Parasrampuria
Original Assignee
Cibus Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cibus Pharmaceutical Inc filed Critical Cibus Pharmaceutical Inc
Publication of MX9704079A publication Critical patent/MX9704079A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Una composicion farmacéutica de suministracion oral para reducir el efecto de irritacion gástrica de un AINE en el tracto GI superior de un mamífero. La composicion incluye (a) una cantidad protectora de la mucosa de una goma hidrocoloide farmacéuticamente aceptable obtenible a partir de plantas superiores, (b) una cantidad mejoradora de dispersion de otro excipiente y (c) una cantidad terapéuticamente efectiva de un ATNE. Se describe también un procedimiento para preparar la composicion y un método para reducir el efecto de irritacion gástrica del AINE al administrar la composicion. Asimismo, se describe una composicion particularmente util para preparar una suspension acuosa.
MX9704079A 1994-12-01 1995-11-30 Liberacion de farmacos antiinflamatorios no esteroides empleando uan goam hidrocoloide en polvo que se obtiene de plantas superiores. MX9704079A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34760194A 1994-12-01 1994-12-01
PCT/US1995/015599 WO1996016639A1 (en) 1994-12-01 1995-11-30 Nsaid delivery employing a powdered hydrocolloid gum obtainable from higher plants

Publications (1)

Publication Number Publication Date
MX9704079A true MX9704079A (es) 1997-12-31

Family

ID=23364417

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9704079A MX9704079A (es) 1994-12-01 1995-11-30 Liberacion de farmacos antiinflamatorios no esteroides empleando uan goam hidrocoloide en polvo que se obtiene de plantas superiores.

Country Status (8)

Country Link
EP (1) EP0804169A4 (es)
JP (1) JPH10509982A (es)
AU (1) AU690417B2 (es)
CA (1) CA2205442C (es)
FI (1) FI972305A0 (es)
MX (1) MX9704079A (es)
NO (1) NO972485L (es)
WO (1) WO1996016639A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811388A (en) * 1995-06-07 1998-09-22 Cibus Pharmaceutical, Inc. Delivery of drugs to the lower GI tract
IL123505A (en) * 1996-07-08 2004-12-15 Penwest Pharmaceuticals Compan Sustained release matrix for high-dose insoluble drugs
US5955107A (en) * 1997-12-12 1999-09-21 Fmc Corporation Pharmaceutical suspension tablet compositions
US6106862A (en) * 1998-08-13 2000-08-22 Andrx Corporation Once daily analgesic tablet
RS50104B (sr) * 1998-08-21 2009-01-22 Novartis Ag., Nova oralna formulacija za 5-th4 agoniste ili antagoniste
SE0003125D0 (sv) * 2000-09-05 2000-09-05 Astrazeneca Ab Modified polymers

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1327938A (en) * 1969-12-17 1973-08-22 Sucrest Corp Composition for use in forming tablets
DE2130545A1 (de) * 1971-06-19 1972-12-21 Merck Patent Gmbh Pharmazeutischer Formkoerper
WO1986006627A1 (en) * 1985-05-15 1986-11-20 Riker Laboratories, Inc. Sustained release theophylline compositions and processes
US5096714A (en) * 1988-06-28 1992-03-17 Hauser-Kuhrts, Inc. Prolonged release drug tablet formulations
US5292534A (en) * 1992-03-25 1994-03-08 Valentine Enterprises, Inc. Sustained release composition and method utilizing xanthan gum and an active ingredient
CA2152795C (en) * 1992-12-30 1999-02-16 Victor Louis King Readily available konjac glucomannan sustained release excipient

Also Published As

Publication number Publication date
NO972485D0 (no) 1997-05-30
JPH10509982A (ja) 1998-09-29
EP0804169A4 (en) 1998-08-19
CA2205442A1 (en) 1996-06-06
FI972305A (fi) 1997-05-30
EP0804169A1 (en) 1997-11-05
FI972305A0 (fi) 1997-05-30
AU4595196A (en) 1996-06-19
WO1996016639A1 (en) 1996-06-06
AU690417B2 (en) 1998-04-23
CA2205442C (en) 2003-01-21
NO972485L (no) 1997-07-31

Similar Documents

Publication Publication Date Title
NZ512792A (en) Stable liquid interferon beta formulations
MY118371A (en) Tetrahydrolipstatin containing compositions
AU6060896A (en) Oral 1alpha-hydroxyprevitamin D
AU7939298A (en) An itraconazole exhibiting an improved solubility, a method of preparing the same and a pharmaceutical composition for oral administration comprising the same
AU2003215110A1 (en) Pharmaceutical dosage form for mucosal delivery
TW355683B (en) Composition containing micronized nebivolol
EG20401A (en) Process for preparing of veterinary composition for the treatment of gastric acid related deseases in animals
RO116342B1 (ro) Compoziţie farmaceutică lichidă, orală
GEP20053473B (en) High Potency Dihydroergotamine Compositions
HUP0104702A2 (hu) Klosztridium toxinszármazékok alkalmazása horkolási zajok elnyomására szolgáló gyógyászati készítmények előállítására
AU1358695A (en) Nasal administration
RU94040387A (ru) Композиция, способствующая прекращению курения, никотиносодержащий распыляемый раствор, способ снижения потребности в курении табака, способ замены курения табака
HUT56494A (en) Process for producing pharmaceutical compositions suitable for peroral administration of pimobendane
BG102857A (en) Antimycotic substance-containing and acetate buffer-containing compositions
CA2388671A1 (en) Magnetic therapeutic mouth piece
IL101056A (en) Composition for nasal treatment
CA2158036A1 (en) 3,4-Diarylchromans for Treatment of Dermatitis
GR3006815T3 (es)
ES2130081A1 (es) Comprimido de maleato de trimebutina con recubrimiento laminar.
MX9704079A (es) Liberacion de farmacos antiinflamatorios no esteroides empleando uan goam hidrocoloide en polvo que se obtiene de plantas superiores.
FI955837A (fi) Menetelmä suun kautta annettavan, kiinteän, diklofenaakkia sisältävän annostelumuodon valmistamiseksi
ATE254851T1 (de) Iod-herstellungszusammensetzung
MX9603092A (es) Nuevos compuestos con efecto analgesico y anestesico local.
MXPA02011533A (es) Nuevas formulaciones de alfa-2,4-disulfofenil-n-terc-butilnitrona.
ZA9010452B (en) Pharmaceutical preparation for oral administration in fluid form